+31 (0)317 466 260 info@amrif.eu

Empowering Innate Immunity

AMRIF focuses on developing safe and well tolerated treatments for chronic inflammatory diseases.

AMRIF is a spin-off company of Alloksys Life Sciences. Leveraging on the RESCAP® platform, we develop therapies for chronic diseases with an underlying problem of systemic inflammation. Our near term focus is on arthritis and diabetic complications.

AMRIF’s human recombinant therapeutic protein hRESCAP has completed a Ph l clinical study.

Meet us

BioEurope Spring

12 March – 14 March, 2018

BioEurope

 5 November – 7 November, 2018